English | 繁體

Search in the results

UM

Browse/Search Results:  1-7 of 7 Help

Selected(0)Clear Items/Page:    Sort:
Quantitatively Lighting up the Spatial Organization of CD47/SIRPα Immune Checkpoints on the Cellular Membrane with Single-Molecule Localization Microscopy Journal article
Wei, Yurong, Zhao, Min, He, Tianpei, Chen, Na, Rao, Li, Chen, Long, Zhang, Yun, Yang, Yanbing, Yuan, Quan. Quantitatively Lighting up the Spatial Organization of CD47/SIRPα Immune Checkpoints on the Cellular Membrane with Single-Molecule Localization Microscopy[J]. ACS Nano, 2023, 17(21), 21626-21638.
Authors:  Wei, Yurong;  Zhao, Min;  He, Tianpei;  Chen, Na;  Rao, Li; et al.
Favorite | TC[WOS]:3 TC[Scopus]:3  IF:15.8/16.2 | Submit date：2024/01/10
Bioimaging  Cd47/sirpα  Immune Checkpoint  Immunotherapy  Super Resolution  
Reprogramming of TAMs via the STAT3/CD47-SIRPα axis promotes acquired resistance to EGFR-TKIs in lung cancer Journal article
Lu, Jiaye, Li, Jingwei, Lin, Ziyou, Li, Huaxuan, Lou, Linlin, Ding, Wen, Ouyang, Shumin, Wu, Yonghui, Wen, Yuanzhen, Chen, Xiaobing, Yue, Peibin, Wang, Yuanxiang, Liu, Peiqing, Lu, Jinjian, Zhang, Jian, Feng, Weineng, Zhang, Xiaolei. Reprogramming of TAMs via the STAT3/CD47-SIRPα axis promotes acquired resistance to EGFR-TKIs in lung cancer[J]. Cancer Letters, 2023, 564, 216205.
Authors:  Lu, Jiaye;  Li, Jingwei;  Lin, Ziyou;  Li, Huaxuan;  Lou, Linlin; et al.
Favorite | TC[WOS]:25 TC[Scopus]:25  IF:9.1/8.3 | Submit date：2023/07/20
Acquired Tki Resistance  Cd47  Lung Cancer  Stat3  Tams  
Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives Review article
2023
Authors:  Ye, Zi Han;  Yu, Wei Bang;  Huang, Mu Yang;  Chen, Jun;  Lu, Jin Jian
Favorite | TC[WOS]:9 TC[Scopus]:10  IF:14.7/14.1 | Submit date：2023/05/02
Bispecific Antibodies  Cancer  Cd47  Clinical Data  Combination Strategies  Future Perspectives  Mechanisms  Preclinical Data  
Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives Journal article
Ye,Zi Han, Yu,Wei Bang, Huang,Mu Yang, Chen,Jun, Lu,Jin Jian. Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives[J]. Acta Pharmaceutica Sinica B, 2023, 13(4), 1467-1487.
Authors:  Ye,Zi Han;  Yu,Wei Bang;  Huang,Mu Yang;  Chen,Jun;  Lu,Jin Jian
Favorite | TC[WOS]:9 TC[Scopus]:10  IF:14.7/14.1 | Submit date：2023/08/03
Bispecific Antibodies  Cancer  Cd47  Clinical Data  Combination Strategies  Future Perspectives  Mechanisms  Preclinical Data  
GcForest-based compound-protein interaction prediction model and its application in discovering small-molecule drugs targeting CD47 Journal article
Shan, Wenying, Chen, Lvqi, Xu, Hao, Zhong, Qinghao, Xu, Yinqiu, Yao, Hequan, Lin, Kejiang, Li, Xuanyi. GcForest-based compound-protein interaction prediction model and its application in discovering small-molecule drugs targeting CD47[J]. Frontiers in Chemistry, 2023, 11.
Authors:  Shan, Wenying;  Chen, Lvqi;  Xu, Hao;  Zhong, Qinghao;  Xu, Yinqiu; et al.
Favorite | TC[WOS]:3 TC[Scopus]:2  IF:3.8/4.8 | Submit date：2024/02/22
Artificial Intelligence  Compound-protein Interaction Prediction  Gcforest  Small-molecule Cd47 Inhibitors  Word2vec  
Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective Journal article
Chen, Yu Chi, Shi, Wei, Shi, Jia Jie, Lu, Jin Jian. Progress of CD47 immune checkpoint blockade agents in anticancer therapy: a hematotoxic perspective[J]. Journal of Cancer Research and Clinical Oncology, 2022, 148(1), 1-14.
Authors:  Chen, Yu Chi;  Shi, Wei;  Shi, Jia Jie;  Lu, Jin Jian
Favorite | TC[WOS]:28 TC[Scopus]:28  IF:2.7/3.1 | Submit date：2022/02/21
Anemia  Cd47/sirpα  Immunotherapy  Macrophages  Phagocytosis Checkpoint  
Regulation of CD47 expression in cancer cells Journal article
Huang,Can Yu, Ye,Zi Han, Huang,Mu Yang, Lu,Jin Jian. Regulation of CD47 expression in cancer cells[J]. Translational Oncology, 2020, 13(12), 100862.
Authors:  Huang,Can Yu;  Ye,Zi Han;  Huang,Mu Yang;  Lu,Jin Jian
Favorite | TC[WOS]:55 TC[Scopus]:61  IF:4.5/4.2 | Submit date：2021/03/02
Cd47  Cytokine  Microrna  Oncogene  Qpctl